Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Last data update: May 24, 2022. (Total: 47325 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 14 (of 14 Records)

Query Trace: Cost-effectiveness[original query]>>Guidelines Related[Product Type]
Raising the bar for Randomized Trials involving Artificial Intelligence: The SPIRIT-AI and CONSORT-AI Guidelines.
Taylor Matthew et al. The Journal of investigative dermatology 2021
Local Coverage Determination (LCD): Genetic Testing for Lynch Syndrome (L34912)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Corus CAD Test (L36713)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Biomarker Testing for Neuroendocrine Tumors/Neoplasms (L37851)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) (L37709)
The U.S. Centers for Medicare & Medicaid Services
Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline.
Lopes Gilberto et al. Journal of global oncology 2019 Feb 51-22
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Amstutz Ursula et al. Clinical pharmacology and therapeutics 2017 Nov
Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant.
Borghesi Alessandro et al. Italian journal of pediatrics 2017 Nov 43(1) 100
Genomic newborn screening: public health policy considerations and recommendations.
Friedman Jan M et al. BMC medical genomics 2017 Feb 10(1) 9
Committee Opinion No. 640: Cell-free DNA Screening for Fetal Aneuploidy.
Obstet Gynecol 2015 Jun 29.
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.
Dondorp Wybo et al. Eur. J. Hum. Genet. 2015 Mar 18.
Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.
Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.
TOP